292 related articles for article (PubMed ID: 34443515)
1. Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses.
Toscani A; Denaro R; Pacheco SFC; Biolatti M; Anselmi S; Dell'Oste V; Castagnolo D
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443515
[TBL] [Abstract][Full Text] [Related]
2. Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model.
Uhlig N; Donner AK; Gege C; Lange F; Kleymann G; Grunwald T
Antiviral Res; 2021 Nov; 195():105190. PubMed ID: 34666109
[TBL] [Abstract][Full Text] [Related]
3. A new promising candidate to overcome drug resistant herpes simplex virus infections.
Zinser E; Krawczyk A; Mühl-Zürbes P; Aufderhorst U; Draßner C; Stich L; Zaja M; Strobl S; Steinkasserer A; Heilingloh CS
Antiviral Res; 2018 Jan; 149():202-210. PubMed ID: 29155164
[TBL] [Abstract][Full Text] [Related]
4. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.
Bhutta MS; Shechter O; Gallo ES; Martin SD; Jones E; Doncel GF; Borenstein R
Viruses; 2021 Jan; 13(1):. PubMed ID: 33435520
[TBL] [Abstract][Full Text] [Related]
5. Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.
Levin MJ; Bacon TH; Leary JJ
Clin Infect Dis; 2004 Nov; 39 Suppl 5():S248-57. PubMed ID: 15494896
[TBL] [Abstract][Full Text] [Related]
6. Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication.
Luganini A; Sibille G; Mognetti B; Sainas S; Pippione AC; Giorgis M; Boschi D; Lolli ML; Gribaudo G
Antiviral Res; 2021 May; 189():105057. PubMed ID: 33716051
[TBL] [Abstract][Full Text] [Related]
7. Antiviral agents for herpes simplex virus.
Vere Hodge RA; Field HJ
Adv Pharmacol; 2013; 67():1-38. PubMed ID: 23885997
[TBL] [Abstract][Full Text] [Related]
8. Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1.
Dávola ME; Mazaira GI; Galigniana MD; Alché LE; Ramírez JA; Barquero AA
Antiviral Res; 2015 Oct; 122():55-63. PubMed ID: 26259812
[TBL] [Abstract][Full Text] [Related]
9. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
[TBL] [Abstract][Full Text] [Related]
10. [Antiviral effect of novel purine conjugate LAS-131 against Herpes simplex virus type 1 (Herpesviridae: Alphaherpesvirinae: Simplexvirus: Human alphaherpesvirus 1) in vitro].
Andronova VL; Galegov GA; Musiyak VV; Vozdvizhenskaya OA; Levit GL; Krasnov VP
Vopr Virusol; 2021 Jan; 65(6):373-380. PubMed ID: 33533233
[TBL] [Abstract][Full Text] [Related]
11. 2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.
Strand M; Islam K; Edlund K; Oberg CT; Allard A; Bergström T; Mei YF; Elofsson M; Wadell G
Antimicrob Agents Chemother; 2012 Nov; 56(11):5735-43. PubMed ID: 22908173
[TBL] [Abstract][Full Text] [Related]
12. Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor.
Schneider SM; Pritchard SM; Wudiri GA; Trammell CE; Nicola AV
mBio; 2019 May; 10(3):. PubMed ID: 31088925
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus resistant to acyclovir: A single-centre experience from the Czech Republic.
Fajfr M; Pliskova L; Bolehovská R; Uhlířová Z; Vrbacký F
J Glob Antimicrob Resist; 2019 Dec; 19():269-273. PubMed ID: 31100505
[TBL] [Abstract][Full Text] [Related]
14. Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus -1: an in vitro study on virally infected Vero and MRC-5 cell lines.
Hafidh RR; Abdulamir AS; Abu Bakar F; Sekawi Z; Jahansheri F; Jalilian FA
BMC Complement Altern Med; 2015 Jun; 15():179. PubMed ID: 26062546
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
[TBL] [Abstract][Full Text] [Related]
16. Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.
Vadlapudi AD; Vadlapatla RK; Mitra AK
Recent Pat Antiinfect Drug Discov; 2013 Apr; 8(1):55-67. PubMed ID: 23331181
[TBL] [Abstract][Full Text] [Related]
17. HSV antivirals - current and future treatment options.
Birkmann A; Zimmermann H
Curr Opin Virol; 2016 Jun; 18():9-13. PubMed ID: 26897058
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus infection.
Whitley RJ
Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
[TBL] [Abstract][Full Text] [Related]
19. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
Lebel A; Boivin G
J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
[TBL] [Abstract][Full Text] [Related]
20. Aminomethylnaphthoquinones and HSV-1: in vitro and in silico evaluations of potential antivirals.
Pires de Mello CP; Sardoux NS; Terra L; Amorim LC; Vargas MD; da Silva GB; Castro HC; Giongo VA; Madeira LF; Paixão IC
Antivir Ther; 2016; 21(6):507-515. PubMed ID: 26913545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
